These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16129066)

  • 1. [Relationship of mitochondrial DNA mutation with myelodysplastic syndromes - review].
    Hou L; Liu T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):709-12. PubMed ID: 16129066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelodysplastic syndromes.
    Greenberg PL; Young NS; Gattermann N
    Hematology Am Soc Hematol Educ Program; 2002; ():136-61. PubMed ID: 12446422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
    Wulfert M; Küpper AC; Tapprich C; Bottomley SS; Bowen D; Germing U; Haas R; Gattermann N
    Exp Hematol; 2008 May; 36(5):577-86. PubMed ID: 18439489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts.
    Nearman ZP; Szpurka H; Serio B; Warshawksy I; Theil K; Lichtin A; Sekeres MA; Maciejewski JP
    Am J Hematol; 2007 Dec; 82(12):1076-9. PubMed ID: 17654685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between mitochondrial DNA and myelodysplastic syndromes - review].
    Zhang QQ; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):712-6. PubMed ID: 18549660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of JAK2 mutations in RARS and other MDS.
    Hellström-Lindberg E; Cazzola M
    Hematology Am Soc Hematol Educ Program; 2008; ():52-9. PubMed ID: 19074058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene mutation and myelodysplastic syndromes with ring sideroblast excess].
    Meng FK; Huang LF; Zhou JF; Sun HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1088-90. PubMed ID: 23998618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes.
    Schildgen V; Wulfert M; Gattermann N
    Exp Hematol; 2011 Jun; 39(6):666-675.e1. PubMed ID: 21447369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplastic syndromes: molecular pathogenesis and genomic changes.
    Nolte F; Hofmann WK
    Ann Hematol; 2008 Oct; 87(10):777-95. PubMed ID: 18516602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.
    Tehranchi R
    Med Oncol; 2006; 23(1):37-49. PubMed ID: 16645228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA variations in myelodysplastic syndrome.
    Gupta M; Madkaikar M; Rao VB; Mishra A; Govindaraj P; Thangaraj K; Ghosh K
    Ann Hematol; 2013 Jul; 92(7):871-6. PubMed ID: 23475051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes.
    Gattermann N
    Leuk Res; 2000 Feb; 24(2):141-51. PubMed ID: 10654450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromes.
    Reddy PL; Shetty VT; Dutt D; York A; Dar S; Mundle SD; Allampallam K; Alvi S; Galili N; Saberwal GS; Anthwal S; Shaikh M; Suleman S; Kamal SY; Raza A
    Br J Haematol; 2002 Mar; 116(3):564-75. PubMed ID: 11849212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
    Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
    Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of human leukocyte antigen class II DRB1*1602 haplotype in Greek patients with myelodysplastic syndrome and of DRB1*1501 in the low-risk subgroup.
    Kritikou-Griva E; Spyropoulou-Vlachou M; Tsagarakis NJ; Goumakou E; Vrani V; Galanopoulos A; Papadhimitriou SI; Androutsos G; Paterakis G; Stavropoulos-Giokas C
    Hum Immunol; 2012 Mar; 73(3):278-81. PubMed ID: 22244918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
    Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
    Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
    Schmitt-Graeff AH; Teo SS; Olschewski M; Schaub F; Haxelmans S; Kirn A; Reinecke P; Germing U; Skoda RC
    Haematologica; 2008 Jan; 93(1):34-40. PubMed ID: 18166783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutation of mitochondria cytochrome oxidase gene in patients with myelodysplastic syndrome].
    Hou L; Liu T; Meng WT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):809-12. PubMed ID: 18718066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.